Levodopa therapy for Parkinson's disease: Challenges and future prospects
Identifieur interne : 002787 ( Main/Exploration ); précédent : 002786; suivant : 002788Levodopa therapy for Parkinson's disease: Challenges and future prospects
Auteurs : C. Warren Olanow [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Jose Obeso [Espagne]Source :
- Movement Disorders [ 0885-3185 ] ; 2008.
English descriptors
- KwdEn :
- Activities of Daily Living, Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Humans, Hypotension (chemically induced), Levodopa (therapeutic use), Nausea (chemically induced), Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Parkinson Disease (psychology), Quality of Life, Vomiting (chemically induced).
- MESH :
- chemical , adverse effects : Antiparkinson Agents.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- chemically induced : Hypotension, Nausea, Vomiting.
- drug therapy : Parkinson Disease.
- physiopathology : Parkinson Disease.
- psychology : Parkinson Disease.
- Activities of Daily Living, Humans, Quality of Life.
Url:
DOI: 10.1002/mds.22048
Affiliations:
- Espagne, Royaume-Uni, États-Unis
- Angleterre, Grand Londres, État de New York
- Londres
- National Hospital for Neurology and Neurosurgery
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 004146
- to stream Istex, to step Curation: 004146
- to stream Istex, to step Checkpoint: 001343
- to stream PubMed, to step Corpus: 002060
- to stream PubMed, to step Curation: 002060
- to stream PubMed, to step Checkpoint: 002238
- to stream Ncbi, to step Merge: 002303
- to stream Ncbi, to step Curation: 002303
- to stream Ncbi, to step Checkpoint: 002303
- to stream Main, to step Merge: 003365
- to stream Main, to step Curation: 002787
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Levodopa therapy for Parkinson's disease: Challenges and future prospects</title><author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name></author><author><name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees (neurologue)</name><affiliation><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><orgName>National Hospital for Neurology and Neurosurgery</orgName></affiliation></author><author><name sortKey="Obeso, Jose" sort="Obeso, Jose" uniqKey="Obeso J" first="Jose" last="Obeso">Jose Obeso</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D35841F7896897E9A53380B2789DC94ED82E0793</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.22048</idno><idno type="url">https://api.istex.fr/document/D35841F7896897E9A53380B2789DC94ED82E0793/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004146</idno><idno type="wicri:Area/Istex/Curation">004146</idno><idno type="wicri:Area/Istex/Checkpoint">001343</idno><idno type="wicri:doubleKey">0885-3185:2008:Olanow C:levodopa:therapy:for</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:18781670</idno><idno type="wicri:Area/PubMed/Corpus">002060</idno><idno type="wicri:Area/PubMed/Curation">002060</idno><idno type="wicri:Area/PubMed/Checkpoint">002238</idno><idno type="wicri:Area/Ncbi/Merge">002303</idno><idno type="wicri:Area/Ncbi/Curation">002303</idno><idno type="wicri:Area/Ncbi/Checkpoint">002303</idno><idno type="wicri:Area/Main/Merge">003365</idno><idno type="wicri:Area/Main/Curation">002787</idno><idno type="wicri:Area/Main/Exploration">002787</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Levodopa therapy for Parkinson's disease: Challenges and future prospects</title><author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mount Sinai School of Medicine, New York, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees (neurologue)</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neurology, Reta Lila Institute of Neurological Studies, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><orgName>National Hospital for Neurology and Neurosurgery</orgName></affiliation></author><author><name sortKey="Obeso, Jose" sort="Obeso, Jose" uniqKey="Obeso J" first="Jose" last="Obeso">Jose Obeso</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Neurology, University of Navarra, Pamplona</wicri:regionArea><wicri:noRegion>Pamplona</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008">2008</date><biblScope unit="vol">23</biblScope><biblScope unit="issue">S3</biblScope><biblScope unit="supplement">S3</biblScope><biblScope unit="page" from="S495">S495</biblScope><biblScope unit="page" to="S496">S496</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">D35841F7896897E9A53380B2789DC94ED82E0793</idno><idno type="DOI">10.1002/mds.22048</idno><idno type="ArticleID">MDS22048</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Activities of Daily Living</term><term>Antiparkinson Agents (adverse effects)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Humans</term><term>Hypotension (chemically induced)</term><term>Levodopa (therapeutic use)</term><term>Nausea (chemically induced)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (physiopathology)</term><term>Parkinson Disease (psychology)</term><term>Quality of Life</term><term>Vomiting (chemically induced)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Hypotension</term><term>Nausea</term><term>Vomiting</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Activities of Daily Living</term><term>Humans</term><term>Quality of Life</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><affiliations><list><country><li>Espagne</li><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Grand Londres</li><li>État de New York</li></region><settlement><li>Londres</li></settlement><orgName><li>National Hospital for Neurology and Neurosurgery</li></orgName></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name></region></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees (neurologue)</name></region></country><country name="Espagne"><noRegion><name sortKey="Obeso, Jose" sort="Obeso, Jose" uniqKey="Obeso J" first="Jose" last="Obeso">Jose Obeso</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002787 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002787 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D35841F7896897E9A53380B2789DC94ED82E0793
|texte= Levodopa therapy for Parkinson's disease: Challenges and future prospects
}}
| This area was generated with Dilib version V0.6.23. |  |